美国商业保险膀胱过度活动症患者三线治疗模式的当代分析
基于2015-2017年MarketScan理赔数据,共识别7383例接受三线治疗的膀胱过度活动症患者。骶神经刺激使用最多(48.8%),经皮胫神经刺激最少(12.9%)。经皮胫神经刺激更多见于都市区、55岁以上及健康维护组织参保者。
要点
- 三线治疗中骶神经刺激占48.8%,经皮胫神经刺激仅12.9%。
- 经皮胫神经刺激患者更多居住都市区、年龄≥55岁、参保健康维护组织。
- 泌尿外科医生最常实施骶神经刺激,妇科医生最常实施膀胱内肉毒毒素A。
核心结论
- 在接受三线治疗的膀胱过度活动症患者中,经皮胫神经刺激使用频率较低。
- 经皮胫神经刺激的使用集中在都市区、老年患者及参保成本控制型健康维护组织的患者中。
研究设计与样本
- 基于MarketScan理赔数据(2015-2017)的回顾性队列研究。
- 共纳入7383例接受三线膀胱过度活动症治疗的患者,平均年龄50.9岁。
主要发现
- 骶神经刺激使用最频繁(n=3602,48.8%),经皮胫神经刺激使用最少(n=955,12.9%)。
- 经皮胫神经刺激患者更可能居住都市区(对比膀胱内肉毒毒素A:OR 1.6,95%CI 1.3-2.1;对比骶神经刺激:OR 2.2,95%CI 1.7-2.8)。
- 经皮胫神经刺激患者更可能年龄≥55岁(对比膀胱内肉毒毒素A:54% vs 47%,OR 1.6,95%CI 1.2-2.1;对比骶神经刺激:54% vs 45%,OR 1.6,95%CI 1.2-2.0)。
- 经皮胫神经刺激患者更可能参保健康维护组织(对比膀胱内肉毒毒素A:17% vs 10%;对比骶神经刺激:17% vs 10%,P<.01)。
- 泌尿外科医生最常实施骶神经刺激,妇科医生最常实施膀胱内肉毒毒素A;91%的经皮胫神经刺激操作在诊室完成。
临床怎么用
- 临床选择三线治疗时需考虑患者居住地、年龄及保险类型对经皮胫神经刺激可及性的影响。
- 经皮胫神经刺激多在诊室实施,适合都市区老年患者及健康维护组织参保者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate utilization of third-line overactive bladder (OAB) treatments including percutaneous tibial nerve stimulation (PTNS), sacral nerve stimulation (SNS), and intradetrusor botulinum toxin A (BTX) among privately insured patients and examine factors associated with their use. MATERIALS AND METHODS: Using MarketScan claims (2015-2017), we identified patients who underwent third-line OAB treatments based on procedure codes. Factors of interest included location, age, health plan, among others. We fit multivariable logistic regression models to estimate associations between pertinent factors with receipt of PTNS and SNS relative to BTX and associations between provider type and practice location with each treatment modality. RESULTS: We identified 7383 patients (mean age 50.9) in our cohort. SNS was used most frequently (n = 3602, 48.8%), while PTNS was used least frequently (n = 955, 12.9%). PTNS patients were more likely to reside in metropolitan areas (vs BTX: OR 1.6, 95%CI 1.3-2.1; vs SNS: OR 2.2, 95%CI 1.7-2.8), be aged 55 years or older (vs BTX: 54% vs 47%, OR 1.6, 95%CI 1.2-2.1; vs SNS: 54% vs 45%, OR 1.6, 95%CI 1.2-2.0), and be covered under a health maintenance organization (vs BTX: 17% vs 10%; vs SNS: 17% vs 10%, P <.01). Urologists were most likely to perform SNS, and gynecologists were most likely to perform BTX. 91% of PTNS procedures were performed in office settings. CONCLUSION: Among patients receiving third-line OAB treatment, PTNS was used infrequently. PTNS utilization was concentrated within urban areas, and among older patients and those covered by cost-conscious health maintenance organizations.
引用
- Jiang J, Patil D, Traore EJ, et al. Contemporary Patterns of Third-line Treatments for Privately Insured Individuals With Overactive Bladder in the United States. Urology. 2020. PMID: 32437771. doi:10.1016/j.urology.2020.04.102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。